METHOTREXATE 15mg. IP

A disease‐modifying anti‐rheumatic drug (DMARD) that treats several immune-mediated inflammatory joint and skin diseases, especially rheumatoid arthritis and moderate-to-severe psoriasis. (Gino Antonio Vena, 2018) A promising drug for the treatment of rheumatoid arthritis as well as many rheumatic diseases by decreasing the activity of the immune system. (Wanruchada Katchamart, 2010) The cornerstone of therapy for autoimmune arthritis, including rheumatoid arthritis, and juvenile idiopathic arthritis. (Rakesh K. Singh, 2019) Shows significant reductions in the number of tender or painful joints, the duration of morning stiffness, and disease progression in patients with refractory rheumatoid arthritis. (M E Weinblatt, 1985) An effective treatment for both extended oligoarticular and systemic juvenile idiopathic arthritis. (P Woo, 2000) The most effective and commonly used medicine to treat various forms of arthritis and other rheumatic conditions. (Juergen Braun, 2009) The most effective disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) with less toxicity and better tolerability. (Wanruchada Katchamart, 2010) More effective and better-tolerated agent than auranofin that displays significantly greater improvement in painful and swollen joints in rheumatoid arthritis patients. (M E Weinblatt H. K., 1990)